{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:07:46Z","timestamp":1761764866862,"version":"3.33.0"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,7,20]],"date-time":"2006-07-20T00:00:00Z","timestamp":1153353600000},"content-version":"vor","delay-in-days":4187,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Pediatr. Oncol."],"published-print":{"date-parts":[[1995,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The outcome of 171 children with ALL who relapsed for the first time after elective cessation of therapy (1\u201386 mo) and followed over 10 years (median 60 mo; range 1\u2013232 mo) has been evaluated. One hundred and three patients relapsed in the bone marrow (BM), 29 in the testis (T), 21 in the central nervous system (CNS), 14 in the BM plus another site and 4 in other sites. Second remission was achieved in 97% of patients (97% BM, 100% T, 90% CNS, respectively) with reinduction schedules including three or more drugs. All but 4 out of 100 patients who relapsed in the BM received cranial reprophylaxis with intrathecal CT alone or CT plus radiotherapy. Seven patients in second CR underwent allogeneic bone marrow transplantation from an HLA matched sibling. The overall survival was 34% and disease\u2010free survival (DFS) probability at 100 years was 22%. A second relapse was observed in 73% of patients. Forty children are alive in second continuous remission and 24 are alive after a second or subsequent relapse. Patients with isolated T relapse showed a significant better outcome than those with BM or CNS involvement. Most patients (62%) with isolated BM relapse showed a further disease recurrence in BM, and DFS was shorter when relapse occurred within 12 months from off\u2010therapy. Eighty\u2010two patients in second CR stopped the treatment a second time and showed a survival and DFS probabilities, respectively, of 69% and 43%.<\/jats:p><jats:p>Thus, children with ALL who relapse after cessation of therapy still have a high risk of further late relapses and should be treated with intensive chemotherapy and CNS reprophylaxis. BMT must be considered for all patients relapsing in the BM within 12 months from off\u2010therapy. \u00a9 1995 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/mpo.2950240202","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T19:24:45Z","timestamp":1171999485000},"page":"71-76","source":"Crossref","is-referenced-by-count":34,"title":["Relapse after first cessation of therapy in childhood acute lymphoblastic leukemia: A 10\u2010year follow\u2010up study"],"prefix":"10.1002","volume":"24","author":[{"given":"R.","family":"Miniero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Saracco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Zurlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Terracini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Masera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,20]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860715)58:2 <590::AID-CNCR2820581330>3.0.CO;2-5"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)90128-0"},{"key":"e_1_2_1_4_2","first-page":"202","article-title":"First isolated bone marrow relapse in children receiving chemotherapy for ALL","volume":"68","author":"Dim G","year":"1983","journal-title":"Haematologica"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/08880018609031207"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1971.03180300032007"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607313150501"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","unstructured":"ChessellsJM BreatnachF: Late marrow recurrences in childhood acute lymphoblastic leukemia.Br Med J:749\u2013751 1981.","DOI":"10.1136\/bmj.283.6294.749"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1200\/JCO.1984.2.10.1088","article-title":"Outcome following late marrow relapse in childhood acute lymphoblastic leukemia","volume":"2","author":"Chessells JM","year":"1984","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197902083000601"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950160106"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197604)37:4<1679::AID-CNCR2820370411>3.0.CO;2-8"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950090507"},{"key":"e_1_2_1_14_2","first-page":"1","article-title":"Outcome after cessation of therapy in childhood leukemia","volume":"354","author":"Nygaard R","year":"1989","journal-title":"Acta Pediatr Scand Suppl"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197808)42:2 <839::AID-CNCR2820420705>3.0.CO;2-P"},{"key":"e_1_2_1_16_2","unstructured":"MaseraG ZurloMG SenesiE HauptR Cordero di MontezemoloL MeloniG CeciA ManciniAF Di GilioG TamaroP TerraciniB:Outcome of children reaching treatment suspension after acute leukemia. 4th International Symposium of Therapy of Acute Leukemias Rome February 7\u201312 1987(Abs. 66)."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860301)57:5<1052::AID-CNCR2820570530>3.0.CO;2-0"},{"key":"e_1_2_1_18_2","first-page":"95","article-title":"Treatment of acute lymphoblastic leukemia in children, the Italian AIEOP experience","volume":"1","author":"Paolucci G","year":"1989","journal-title":"Bone Marrow Transplant 4, Suppl"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/08880018609031195"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_1_21_2","first-page":"163","article-title":"Evaluation of survival data and two new route order statistics arising in its consideration","volume":"50","author":"Mantel N","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression model and life table","volume":"34","author":"Cox DR","year":"1972","journal-title":"J Roy Stat Soc B"},{"key":"e_1_2_1_23_2","first-page":"75","article-title":"Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukemia in second remission","volume":"1","author":"Bacigalupo A","year":"1986","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91387-5"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198110083051502"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950130402"},{"issue":"2","key":"e_1_2_1_27_2","article-title":"For the GITMO: An Italian multicenter study comparing allogenic BMT versus autologous BMT in childhood acute lymphoblastic leukemia in 2nd remission","volume":"5","author":"Uderzo C","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood.V53.6.1114.1114","article-title":"Second cessation of therapy in childhood lymphocytic leukemia","volume":"53","author":"Rivera G","year":"1979","journal-title":"Blood"},{"key":"e_1_2_1_29_2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood.V78.5.1166.1166","article-title":"Six\u2010year experience with a comprehensive approach in the treatment of recurrent childhood acute lymphoblastic leukemia (ALL\u2010REZ BFM). A relapse study of the BFM group","volume":"78","author":"Henze G","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607313150501"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood.V78.10.2780.2780","article-title":"Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM and CoALL\u2010protocols: Results of the german cooperative study","volume":"78","author":"Dopfer R","year":"1991","journal-title":"Blood"}],"container-title":["Medical and Pediatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmpo.2950240202","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mpo.2950240202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T23:18:03Z","timestamp":1736810283000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mpo.2950240202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["10.1002\/mpo.2950240202"],"URL":"https:\/\/doi.org\/10.1002\/mpo.2950240202","archive":["Portico"],"relation":{},"ISSN":["0098-1532","1096-911X"],"issn-type":[{"type":"print","value":"0098-1532"},{"type":"electronic","value":"1096-911X"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}